Skip to main content
Fig. 4 | Insights into Imaging

Fig. 4

From: Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis

Fig. 4

61-year-old male patient with COVID-19-associated SSC after severe COVID-19 infection and prolonged ICU stay. a Axial non-fat-suppressed and (b) fat-suppressed T2-weighted images show mild hyperintense signal changes predominantly in the right hepatic lobe (arrows in a and b) with subtle bile duct dilatation (arrowheads in a and b). The caudate lobe is enlarged, and the hepatic contours are rounded (long arrows in a and b). c Maximum intensity projection MRCP image shows irregularities of the intrahepatic bile ducts with beading and multifocal structuring (arrows). The extrahepatic biliary tree is spared (long arrows). d Post-contrast images in the arterial phase show diffuse areas of patchy hyperenhancement especially in peripheral areas of the right hepatic lobe (arrows). d The post-contrast images in the hepatobiliary phase show patchy hypointense changes representing areas of decreased of hepatobiliary contrast agent uptake (arrows). f Color stiffness map from MR elastography shows increased stiffness of the liver parenchyma (arrows) as represented by the yellow to red color coding (mean liver stiffness was 6.4 kPa)

Back to article page